EUVIMEDEUVIMED entdecken
Crossref

Is Primary Tumor Size Still the Main Barrier to Active Surveillance?

Fernanda Vaisman

Clinical Thyroidology® · 01.08.2026 · 38 (8) · 282-285

DOI: 10.1177/23299711261475848 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical Thyroidology®, online erschienen am 10.08.2026. Verfasst von Fernanda Vaisman. Die Arbeit nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Vaisman, F. (2026). Is Primary Tumor Size Still the Main Barrier to Active Surveillance?. Clinical Thyroidology®, 38(8), 282-285. https://doi.org/10.1177/23299711261475848

Vancouver

Vaisman F. Is Primary Tumor Size Still the Main Barrier to Active Surveillance?. Clinical Thyroidology®. 2026;38(8):282-285. doi:10.1177/23299711261475848

BibTeX
@article{Vaisman2026,
  author = {Vaisman, Fernanda},
  title = {Is Primary Tumor Size Still the Main Barrier to Active Surveillance?},
  journal = {Clinical Thyroidology®},
  year = {2026},
  volume = {38},
  number = {8},
  pages = {282--285},
  doi = {10.1177/23299711261475848}
}
Kostenlos starten →